Familial Hypertrophic Cardiomyopathy

Common Name(s)

Familial Hypertrophic Cardiomyopathy

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Familial Hypertrophic Cardiomyopathy" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Familial Hypertrophic Cardiomyopathy" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Familial Hypertrophic Cardiomyopathy" returned 126 free, full-text research articles on human participants. First 3 results:

Reversible heart failure with left ventricular dysfunction in a postpartum woman with familial hypertrophic cardiomyopathy.
 

Author(s): Sharon Perlman, Ofir Paz, Zion Hagay, Sara Shimoni, Avraham Caspi, Sorel Goland

Journal: Isr. Med. Assoc. J.. 2013 May;15(5):256-7.

 

Last Updated: 11 Jul 2013

Go To URL
Discrete effects of A57G-myosin essential light chain mutation associated with familial hypertrophic cardiomyopathy.
 

Author(s): Katarzyna Kazmierczak, Ellena C Paulino, Wenrui Huang, Priya Muthu, Jingsheng Liang, Chen-Ching Yuan, Ana I Rojas, Joshua M Hare, Danuta Szczesna-Cordary

Journal: Am. J. Physiol. Heart Circ. Physiol.. 2013 Aug;305(4):H575-89.

 

The functional consequences of the familial hypertrophic cardiomyopathy A57G (alanine-to-glycine) mutation in the myosin ventricular essential light chain (ELC) were assessed in vitro and in vivo using previously generated transgenic (Tg) mice expressing A57G-ELC mutant vs. wild-type ...

Last Updated: 16 Aug 2013

Go To URL
Familial hypertrophic cardiomyopathy: is the Frank-Starling law kaput?
 

Author(s): Sabine Huke, Björn C Knollmann

Journal: Circ. Res.. 2013 May;112(11):1409-11.

 

Last Updated: 24 May 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Familial Hypertrophic Cardiomyopathy" returned 7 free, full-text review articles on human participants. First 3 results:

Multi-scale computational models of familial hypertrophic cardiomyopathy: genotype to phenotype.
 

Author(s): Stuart G Campbell, Andrew D McCulloch

Journal: J R Soc Interface. 2011 Nov;8(64):1550-61.

 

Familial hypertrophic cardiomyopathy (FHC) is an inherited disorder affecting roughly one in 500 people. Its hallmark is abnormal thickening of the ventricular wall, leading to serious complications that include heart failure and sudden cardiac death. Treatment is complicated by variation ...

Last Updated: 28 Sep 2011

Go To URL
[Malignant form of familial hypertrophic cardiomyopathy complicated with ventricular fibrillation in siblings. Electrocardiogram in hypertrophic cardiomyopathy - a review].
 

Author(s): Piotr Kukla, Paweł Petkow-Dimitrow, Marek Jastrzebski, Jacek Bednarek, Jacek Lelakowski, Leszek Bryniarski

Journal: Kardiol Pol. 2009 Jul;67(7):774-80; discussion 781.

 

A family with hypertrophic cardiomyopathy (HCM) (15-year-old boy, his 17-year-old sister and 45-year-old father) is described. The first sign of HCM was cardiac arrest (CA) due to ventricular fibrillation (VF) in a boy. A few months later sister of proband had the episode of CA due ...

Last Updated: 3 Aug 2009

Go To URL
Myosin binding protein C: structural abnormalities in familial hypertrophic cardiomyopathy.
 

Author(s): Cecily E Oakley, Brett D Hambly, Paul M G Curmi, Louise J Brown

Journal: Cell Res.. 2004 Apr;14(2):95-110.

 

The muscle protein myosin binding protein C (MyBPC) is a large multi-domain protein whose role in the sarcomere is complex and not yet fully understood. Mutations in MyBPC are strongly associated with the heart disease familial hypertrophic cardiomyopathy (FHC) and these experiments ...

Last Updated: 29 Apr 2004

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

CArdiac Desynchronization In Obstructive HCM, CARDIO-HCM
 

Status: Not yet recruiting

Condition Summary: Hypertrophic Obstructive Cardiomyopathy (HOCM)

 

Last Updated: 19 Mar 2013

Go to URL
Congenital Muscle Disease Study of Patient and Family Reported Medical Information
 

Status: Recruiting

Condition Summary: Muscular Dystrophy; Congenital Muscular Dystrophy; Fukutin-related Protein Gene; Limb Girdle; FKRP Gene; Childhood Onset LGMD; Adult Onset LGMD; POMT1; POMT2; POMGnT1; LARGE; Alpha Dystroglycan; Dystroglycanopathy; Centronuclear; Multiminicore; Multicore; Minicore; Congenital Fiber Type Disproportion; Myotubular; Nemaline; Congenital Myopathy; Neuromuscular; Rigid Spine; Phenotype-Genotype Correlation; Cough Assisted Device; Neuromuscular Disease; Respiratory Exacerbation; Invasive Ventilation; Chest Physiotherapy; Congenital Myopathies; Genetic Mutations; Hypertrophic Cardiomyopathy; Wheelchair Use; Cataract; Opthalmoplegia; Ullrich Congenital Muscular Dystrophy; Intermediate Collagen VI Myopathy; Laminin Alpha 2 Related Congenital Muscular Dystrophy; MDC1A; Merosin Deficient Congenital Muscular Dystrophy; Congenital Muscular Dystrophy Undiagnosed; Congenital Muscular Dystrophy Merosin Positive; Walker Warburg Syndrome; Muscle Eye Brain Disease; Fukuyama; Integrin Alpha 7 Deficiency; Integrin Alpha 9 Deficiency; Laminopathy; Lamin AC; SEPN 1 Related Myopathies; Bethlem Myopathy; Dystroglycanopathies; LGMD2K; LGMD2I; LGMD2L; LGMD2N; Actin Aggregation Myopathy; Cap Disease; Central Core Disease; Centronuclear Myopathy; Core Rod Myopathy; Hyaline Body Myopathy; Multiminicore Myopathy; Myotubular Myopathy; Nemaline Myopathy; Tubular Aggregate Myopathy; Zebra Body Disease Myopathy; Congenital Myopathy Other; Reducing Body Myopathy; Sarcotubular Myopathy; Spheroid Body Myopathy

 

Last Updated: 17 Jun 2014

Go to URL